You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

Drug Price Trends for NDC 00172-5241


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 00172-5241

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

00172-5241 Market Analysis and Financial Projection

Market Analysis and Price Projections for the Drug NDC: 00172-5241

Understanding the NDC Number

The National Drug Code (NDC) number, in this case 00172-5241, is a unique identifier assigned to each drug product by the Food and Drug Administration (FDA). This code is crucial for various aspects of pharmaceutical operations, including prescribing, dispensing, reimbursement, and supply chain management[1].

Drug Identification

To analyze the market and price projections for the drug with NDC 00172-5241, it is essential to identify the specific drug product associated with this code. However, the provided sources do not specify the drug directly linked to this NDC number. Typically, one would refer to the FDA's NDC Directory or other pharmaceutical databases to identify the drug[5].

General Market Trends in Pharmaceuticals

Despite the lack of specific details on the drug associated with NDC 00172-5241, we can discuss general market trends and factors that influence drug prices and market projections.

Drug Price Inflation

The pharmaceutical industry is experiencing ongoing price inflation. For instance, Vizient projects a 3.81% overall drug price inflation rate for 2025, driven by factors such as expanding indications for previously approved medications and the introduction of high-cost cell and gene therapies[2].

Impact of Generic and Biosimilar Drugs

The market is also influenced by the availability of generic and biosimilar drugs. The patent expiration of blockbuster drugs can significantly impact market dynamics. For example, in the non-small cell lung cancer (NSCLC) market, the patent expiration of drugs like Tarceva and Alimta has led to a decline in their sales, while generic versions have seen an increase[4].

Advanced Therapies and Personalized Medicine

The life sciences industry is shifting towards more personalized and advanced therapies. This includes the integration of genomics, biomarkers, and technologies like gen AI, which are expected to enhance treatment efficacy and reduce side effects. Such advancements can drive market growth but also introduce new pricing and access challenges[3].

Specific Market Analysis for Similar Drugs

While the exact drug associated with NDC 00172-5241 is not specified, we can look at similar market analyses for drugs within the same therapeutic categories.

Example: NSCLC Market

In the NSCLC market, premium-priced immune checkpoint inhibitors and targeted therapies are driving significant growth. Drugs like Keytruda, Opdivo, and Tecentriq are projected to achieve blockbuster status by 2025, with sales reaching $17.5 billion collectively. This growth is driven by their increasing use in first-line treatments and their effectiveness in various patient populations[4].

Price Projections

Price projections for a specific drug would depend on several factors, including its therapeutic category, competition from generics or biosimilars, regulatory changes, and market demand.

Factors Influencing Price

  • Regulatory Changes: Changes in the NDC format or other regulatory adjustments can impact the operational and economic aspects of drug pricing and distribution[1].
  • Competition: The entry of generic or biosimilar versions can significantly reduce the prices of branded drugs.
  • Market Demand: Increasing demand due to expanding indications or new approvals can drive up prices.
  • Technological Advancements: Integration of technologies like gen AI can improve operational efficiencies but may also introduce new pricing strategies.

Key Takeaways

  • The pharmaceutical industry is experiencing significant changes driven by regulatory updates, technological advancements, and market dynamics.
  • Drug price inflation is a continuous trend, with projections indicating a 3.81% increase in 2025.
  • The impact of generic and biosimilar drugs on market prices cannot be understated.
  • Advanced therapies and personalized medicine are driving growth but also introduce new challenges in pricing and access.

FAQs

  1. What is the significance of the NDC number in the pharmaceutical industry?

    • The NDC number is a unique identifier for each drug product, crucial for prescribing, dispensing, reimbursement, and supply chain management.
  2. How does drug price inflation affect the pharmaceutical market?

    • Drug price inflation, such as the projected 3.81% increase in 2025, impacts provider budgets and operational processes, particularly with the introduction of high-cost therapies.
  3. What role do generic and biosimilar drugs play in market dynamics?

    • Generic and biosimilar drugs can significantly reduce the prices of branded drugs upon patent expiration, affecting market sales and growth.
  4. How are advanced therapies and personalized medicine impacting the market?

    • These advancements are driving growth by improving treatment efficacy and reducing side effects but also introduce new pricing and access challenges.
  5. What are the key factors influencing drug price projections?

    • Factors include regulatory changes, competition from generics or biosimilars, market demand, and technological advancements.

Sources

  1. Wolters Kluwer - Are You Prepared for a Major Industry Change to the National Drug Code (NDC) Number?
  2. Vizient, Inc. - Vizient projects drug price inflation at 3.81%
  3. Deloitte Insights - 2025 life sciences outlook
  4. GlobalData - NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025
  5. YouTube - NDC Directory (March 2015)

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.